Inmunatur ApS: Financial statements 2024
CVR: 43382381
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Inmunatur ApS (CVR 43382381) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 111,637 and a net result of DKK 4,710. The profit margin was 4.2%. Equity in the 2024 report amounted to DKK 18,029. The solvency ratio was 100%.
- Revenue
- DKK 111,637
- Gross Profit
- DKK 6,038
- Profit/Loss
- DKK 4,710
- Equity
- DKK 18,029
- Total Assets
- DKK 18,029
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Inmunatur ApS has published its interim report for the period July 7, 2022 to December 31, 2023.
As of March 15, 2024, Jannie Solberg has joined the board of directors of Inmunatur ApS.
As of March 15, 2024, Karna Judith Kiel Madsen has joined the board of directors of Inmunatur ApS.
As of March 15, 2024, Karna Judith Kiel Madsen is registered as adm. dir. of Inmunatur ApS.
As of March 15, 2024, Jannie Solberg has stepped down as adm. dir. of Inmunatur ApS.
As of March 14, 2024, Jannie Solberg has left the board of directors of Inmunatur ApS.
As of March 14, 2024, Karna Judith Kiel Madsen has left the board of directors of Inmunatur ApS.
About Inmunatur ApS
Inmunatur ApS is a Danish company of the type Anpartsselskab based in Søndersø, founded in 2022. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Karna Judith Kiel Madsen. The board consists of Karna Judith Kiel Madsen (chair) and Jannie Solberg. The company is owned by Jannie Solberg and Karna Judith Kiel Madsen. In 2025, the company reported revenue of DKK 46,282 and a net result of DKK -15,402 compared with DKK 4,710 the year before. Equity in the 2025 report amounted to DKK 2,620.